115 related articles for article (PubMed ID: 27761620)
1. Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? - Wait for confirmation study : Reply to Jorgov et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1220--30.
Kluge R; Kurch L; Georgi T; Hasenclever D
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):170-171. PubMed ID: 27761620
[No Abstract] [Full Text] [Related]
2. Reply.
Jorgov L; Montravers F; Balogova S; Landman-Parker J; Talbot JN
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):172. PubMed ID: 27730331
[No Abstract] [Full Text] [Related]
3. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.
Jorgov L; Montravers F; Balogova S; Ragu C; Pacquement H; Leblanc T; Abbou S; Ducou-Lepointe H; Landman-Parker J; Talbot JN
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1220-30. PubMed ID: 26660144
[TBL] [Abstract][Full Text] [Related]
4. Letter to the editor concerning "Reproducibility of [
Livingstone J; Berovic M; Peters AM
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):342-343. PubMed ID: 37962620
[No Abstract] [Full Text] [Related]
5. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
6. Intense 18F-FDG Uptake in Chronic Subcutaneous Opioid Injection Sites.
Salas Fragomeni RA; Rowe SP
Clin Nucl Med; 2016 Oct; 41(10):e456-7. PubMed ID: 27405027
[TBL] [Abstract][Full Text] [Related]
7. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
[TBL] [Abstract][Full Text] [Related]
8. FDG-pet in paraneoplastic syndromes.
Linke R; Voltz R
Recent Results Cancer Res; 2008; 170():203-11. PubMed ID: 18019628
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay C; Lépine M; Verreault J; Bénard F
J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin lymphoma-associated paraneoplastic cerebellar degeneration on FDG-PET/CT.
Gheysens O; Deroose CM; Tousseyn T; Goffin K; Verhoef G; Dierickx D
Br J Haematol; 2014 Feb; 164(4):468. PubMed ID: 24460525
[No Abstract] [Full Text] [Related]
11. [18F-FDG uptake of lymphoma lesions of various histological subtypes].
Ma LF; Fan W
Ai Zheng; 2009 Apr; 28(4):425-30. PubMed ID: 19622306
[TBL] [Abstract][Full Text] [Related]
12. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
14. Unusual loss of FDG uptake in recurrent GIST.
Dunzinger A; Decker J; Kieberger A; Weis S; Pichler R
Nuklearmedizin; 2014 Aug; 53(4):N35-7. PubMed ID: 25100559
[No Abstract] [Full Text] [Related]
15. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
Hong JH; Jung US; Min KJ; Lee JK; Kim S; Eo JS
Nucl Med Commun; 2016 Aug; 37(8):843-8. PubMed ID: 27058362
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT.
Akhtar S; Al-Sugair AS; Abouzied M; Alkadhi Y; Dingle M; Abdelsalam M; Soudy H; Darwish A; Eltigani A; Elhassan TA; Nabil-Ahmed M; Maghfoor I
Bone Marrow Transplant; 2013 Nov; 48(12):1530-6. PubMed ID: 23749108
[TBL] [Abstract][Full Text] [Related]
17. Evolving role of positron emission tomography in breast cancer imaging.
Eubank WB; Mankoff DA
Semin Nucl Med; 2005 Apr; 35(2):84-99. PubMed ID: 15765372
[TBL] [Abstract][Full Text] [Related]
18. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations].
Wickmann L; Lüders H; Dörffel W
Klin Padiatr; 2003; 215(3):146-50. PubMed ID: 12778354
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.
Cencini E; Fabbri A; Rigacci L; Lazzi S; Gini G; Cox MC; Mancuso S; Abruzzese E; Kovalchuk S; Goteri G; Di Napoli A; Bono R; Fratoni S; Di Lollo S; Bosi A; Leoncini L; Bocchia M
Hematol Oncol; 2017 Mar; 35(1):69-78. PubMed ID: 26251194
[TBL] [Abstract][Full Text] [Related]
20. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
